Clinical Outcomes by Albuminuria Status with Dulaglutide versus Insulin Glargine in Participants with Diabetes and CKD: AWARD-7 Exploratory Analysis | American Society of Nephrology
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program - Jendle -
Mode of administration of dulaglutide: implications for treatment adhe | PPA
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials | SpringerLink
Safety and Efficacy of Dulaglutide, a Once Weekly GLP-1 Receptor Agonist, for the Management of Type 2 Diabetes Louis Kuritzky, MD1; Guillermo Umpierrez, - ppt video online download
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial - The Lancet
PDF) Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study - The Lancet
Summary of clinical trials evaluating the use of GLP-1 agonists to... | Download Scientific Diagram
Exploring potential mediators of the cardiovascular benefit of dulaglutide in REWIND - Virtual Meeting | EASD
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials | springermedizin.de
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2) | SpringerLink
Once-weekly Dulaglutide and Major Cardiovascular Events—Results of the REWIND Trial – touchENDOCRINOLOGY
Key drivers of clinical differences between once-weekly semaglutide and... | Download Table
Once-weekly Dulaglutide and Major Cardiovascular Events—Results of the REWIND Trial – touchENDOCRINOLOGY
REWIND: Dulaglutide reduces stroke risk in type 2 diabetes
Boan Biotech's Dulaglutide Injection (BA5101) Approved for Clinical Trials in China News - Boan Biotech，ShandongBoan Biotech， Boan Biotech Novel Antibodies，Boan Biotech Biosimilars，Bevacizumab
Clinical Trials: A1C, Weight Change & Cardiovascular Data | HCP | Trulicity (dulaglutide)
Dulaglutide clinical trial program for data analysis | Download Scientific Diagram
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting - Clinical Therapeutics
Safety and Efficacy of Dulaglutide, a Once Weekly GLP-1 Receptor Agonist, for the Management of Type 2 Diabetes Louis Kuritzky, MD1; Guillermo Umpierrez, - ppt video online download
Efficacy and safety of dulaglutide versus placebo and exenatide in type 2 diabetes (AWARD-1) - Virtual Meeting | EASD
